Many therapeutic approaches to cancer affect the tumour vasculature, either indirectly or as a direct target. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has become an important means of investigating this action, both pre-clinically and in early stage clinical trials. For such trials, it is essential that the measurement process (i.e. image acquisition and analysis) can be performed effectively and with consistency among contributing centres. As the technique continues to ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.
If you are the owner of this record, you can report an update to it here: Report update to this record